Most recently, Gullotti et al. observed that FHL2 activation and nuclear transactivation occurs much more intensively in sporadic colon cancers than in microsatellite-instable, hereditary colon cancer and correlates with intensive tissue remodelling and advanced metastasis [8]. The gene discussed is FHL2; the disease is malignant colon neoplasm.